Screening After Hysterectomy for Cancer

Surveillance Protocol Based on Cancer History

The National Comprehensive Cancer Network recommends that women who underwent hysterectomy for cervical cancer continue intensive vaginal cytology surveillance for a minimum of 20-25 years post-surgery, and should strongly consider indefinite screening as long as they remain in reasonably good health, due to persistently elevated risk of vaginal cancer and recurrence 1, 2
Women with a history of invasive cervical cancer should follow a structured surveillance schedule, with vaginal cytology and thorough pelvic examination every 3-4 months for the first 2 years, every 6 months for years 3-5, and annually for years 6-20, with continued indefinite screening if the patient remains in good health 1, 2
The American College of Obstetricians and Gynecologists implicitly supports the National Comprehensive Cancer Network's guideline that there is no upper age limit for stopping surveillance in cervical cancer survivors, as they remain permanently high-risk regardless of time elapsed since treatment 1

High-risk HPV testing combined with vaginal cytology significantly increases detection of vaginal intraepithelial neoplasia (VAIN) and recurrence compared to cytology alone, and is recommended for women with cervical cancer history who have substantially elevated risk for VAIN and vaginal cancer 1

The US Public Health Service and Infectious Disease Society of America recommend that women with in utero DES exposure or who are immunocompromised (HIV-positive, solid organ transplant, stem cell transplant, or chronic immunosuppressant therapy) should continue screening indefinitely, with testing twice during the first year after diagnosis, then annually thereafter 4, 5, 2, 3